Patients with More Severe IBD Get Clostridioides difficile Rather than Clostridioides difficile Increasing the Severity of IBD

被引：0
|
作者：
Sanskriti Varma
Adam S. Faye
Adithya Kannan
Garrett Lawlor
Abhishek Verma
Jordan Axelrad
Daniel E. Freedberg
机构：
[1] New York Presbyterian Columbia University Medical Center,Department of Medicine
[2] Columbia University,Division of Digestive and Liver Diseases, Department of Medicine, College of Physicians and Surgeons
[3] Columbia University,Vagelos College of Physicians and Surgeons
[4] NYU Langone Health,Department of Medicine
[5] NYU School of Medicine,Division of Gastroenterology and Hepatology
来源：
Digestive Diseases and Sciences | 2021年 / 66卷
关键词：
Inflammatory bowel disease; infection; IBD severity; IBD relapse;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3113 / 3123
页数：10
相关论文
共 50 条
  • [31] Outcomes in Patients with SARS-CoV-2 and Clostridioides difficile Coinfection
    Sehgal, Kanika
    Fadel, Hind J.
    Tande, Aaron J.
    Pardi, Darrell S.
    Khanna, Sahil
    INFECTION AND DRUG RESISTANCE, 2021, 14 : 1645 - 1648
  • [32] Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease
    Dalal, Rahul S.
    Allegretti, Jessica R.
    CURRENT OPINION IN GASTROENTEROLOGY, 2021, 37 (04) : 336 - 343
  • [33] Serum procalcitonin levels associate with Clostridioides difficile infection in patients with inflammatory bowel disease
    Mohammad Abdehagh
    Masoumeh Azimirad
    Hamidreza Houri
    Banafsheh Nadalian
    Fahimeh Azimirad
    Meysam Olfatifar
    Ome Kolsoum Nasir Shoeibi
    Abbas Yadegar
    Shabnam Shahrokh
    Mehran Mahdavi Roshan
    Hamid Asadzadeh Aghdaei
    Mohammad Reza Zali
    BMC Infectious Diseases, 21
  • [34] Oral Omilancor Treatment Ameliorates Clostridioides difficile Infection During IBD Through Novel Immunoregulatory Mechanisms Mediated by LANCL2 Activation
    Tubau-Juni, Nuria
    Bassaganya-Riera, Josep
    Leber, Andrew J.
    Alva, Sameeksha S.
    Hontecillas, Raquel
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (01) : 103 - 113
  • [35] Zinc Deficiency in IBD Patients with Recurrent Clostridium Difficile Infection
    Niccum, Blake
    Stein, Daniel
    Behm, Brian
    Hays, Rachel
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S27 - S28
  • [36] Antibiotic use and risk of Clostridioides difficile infection in patients with inflammatory bowel disease
    Bejcek, Alexis
    Ancha, Anupama
    Lewis, Megan
    Beaver, Ryan
    Tecson, Kristen
    Bomar, Jaccallene
    Johnson, Christopher
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (11) : 2417 - 2423
  • [37] Outcomes and risk factors for mortality in clostridioides difficile infection in patients with NAFLD and NASH
    Patel, Ankoor H.
    Pathak, Gaurav N.
    Chen, Alexander
    Greenberg, Patricia
    Mazzaferro, Natale
    Patel, Anish
    Mallangada, Naveen
    Minacapelli, Carlos D.
    Catalano, Kaitlyn
    Suthar, Hansel
    Rustgi, Vinod K.
    ANNALS OF HEPATOLOGY, 2024, 29 (04)
  • [38] Impact of Clostridioides difficile length of treatment on rates of recurrence in patients on concurrent antibiotics
    Rajakumar, Irina
    Jaber, Rami
    Ali, Raafi
    Rennert-May, Elissa
    Sabuda, Deana
    AMERICAN JOURNAL OF INFECTION CONTROL, 2023, 51 (11) : 1213 - 1217
  • [39] Analysis of risk factors of Clostridioides difficile infection in patients with inflammatory bowel disease
    Jakubowska, Alicja
    Szydlarska, Dorota
    Rydzewska, Grazyna
    GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2024, 19 (03): : 277 - 283
  • [40] A genomic survey of Clostridioides difficile isolates from hospitalized patients in Melbourne, Australia
    Larcombe, Sarah
    Williams, Galain C.
    Amy, Jacob
    Lim, Su Chen
    Riley, Thomas V.
    Muleta, Anthony
    Barugahare, Adele A.
    Powell, David R.
    Johanesen, Priscilla A.
    Cheng, Allen C.
    Peleg, Anton Y.
    Lyras, Dena
    MICROBIOLOGY SPECTRUM, 2023, 11 (06):
12345